¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ¸ð°ø°¢È­Áõ ½ÃÈï ±¸¿ùµ¿ Ä¡·á Ãʱ⿡ °ü¸®ÇØ¿ä

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ¸ð°ø°¢È­Áõ, #¼Ûµµ¸ð°ø°¢È­ÁõÄ¡·á, #ÇǺο°, #¼ÛµµÇǺο°, #¸ð°ø°¢È­ÁõÄ¡·á, #ÇǺο°Ä¡·á, #¼ÛµµÇǺο°, #¼Ûµµ¸ð°ø°¢È­Áõ ¼Ûµµ¸ð°ø°¢È­Áõ,,¼Ûµµ¸ð°ø°¢È­ÁõÄ¡·á,,ÇǺο°,,¼ÛµµÇǺο°,,¸ð°ø°¢È­ÁõÄ¡·á,,ÇǺο°Ä¡·á,,¼ÛµµÇǺο°,,¼Ûµµ¸ð°ø°¢È­Áõ ¾È³çÇϼ¼¿ä. ¼Ûµµ¸ð°ø°¢È­Áõ ¼Ûµµ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ¸ð°ø°¢È­Áõ ¼Ûµµ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÇǺο°, ¼Õ¾ÆÅäÇÇ, Àӽŵε巯±â, È­Æó½ÀÁø, Äݸ°¼ºµÎµå·¯±â, ¸ñ¾ÆÅäÇÇ, »ç¸¶±Í, ¾ó±¼È«Á¶, ¾È¸éÈ«Á¶Áõ, ÆÇ»ó°Ç¼±, ¾ó±¼»ç¸¶±Í, Å¿­, ¼Õ°¡¶ô»ç¸¶±Í, µî°Ç¼±, Áö·ç¼ºÇǺο°Ä¡·á, ¾î¸°À̻縶±Í, ¾Æ±â¾ÆÅäÇÇÇǺο°, ¾ÆÅäÇÇÄ¡·á, ¿øÇüÅ»¸ð, ¹ß»ç¸¶±Í, ¾î¸°¼±, ³óÆ÷¼º°Ç¼±, »çŸ±¸´Ï½ÀÁø, °æÇÇÁõ, ¿©¸§¾ÆÅäÇÇµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ¼öÄ¡·á, ³ì¿ë, °ñµµ¹ý°Ë»ç, °æ±ÙÃß³ª¿ä¹ý, ¿µ¾ç±³À°, paraffin, ÇѹæÁ¤½Å¿ä¹ý, °æ¶ôÇâ±â¿ä¹ý, ½½¸µ, ÀιٵðÃøÁ¤, ±¤¿ªµ¿¿ä¹ý, ¼ºÀåÀڱؿä¹ý, ¾È¸éÁ¤Çüħ¼ú, manipulation, ü¿­Áø´Ü(Àü½Å), ºñ¸¸Àüħ, ÀüÀÚ¿ä¹ý, Ȳ·ÃÇص¶ÅÁ¾àħ, ¾óÀ½¿åÁ¶, ü¼ººÐºÐ¼®, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æ³² ±èÇؽà »ï°èµ¿, °æ³² â¿ø½Ã ¸¶»êȸ¿ø±¸ ÇÕ¼º1µ¿, ÀüºÏ ÀÍ»ê½Ã Çö¿µµ¿, ÀüºÏ ÀÍ»ê½Ã ¿ëÁ¦µ¿, °æºÏ ¿µÁֽà ¾ÆÁöµ¿, °æ³² ¾ç»ê½Ã »ïÈ£µ¿, Ãæ³² ¿¹»ê±º ½Å¾Ï¸é, Àü³² ¿µ±¤±º ¿°»ê¸é, °æºÏ ºÀÈ­±º ¼Òõ¸é, ÀÎõ µ¿±¸ ⿵µ¿, ºÎ»ê ¼­±¸ ¾Æ¹Ìµ¿2°¡, °æ±â ¾È¼º½Ã »ç°îµ¿, °æ³² â¿ø½Ã ÁøÇر¸ ¿¬µµµ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ ´Ù°¡µ¿1°¡, °æ³² ¹Ð¾ç½Ã Ãʵ¿¸é, ÃæºÏ ÃæÁֽà ³ëÀº¸é, Àü³² ¸ñÆ÷½Ã ±¤µ¿3°¡, ¿ï»ê ºÏ±¸ ¸íÃ̵¿, °æ±â È­¼º½Ã ±â»êµ¿, ÀüºÏ ¹«ÁÖ±º Àû»ó¸é, ÀüºÏ ±º»ê½Ã ¿Á¼­¸é, °æ±â ¿ëÀνà ¼öÁö±¸ »óÇö2µ¿, ÀÎõ ³²±¸ ÁÖ¾È7µ¿, ºÎ»ê ±ÝÁ¤±¸ ºÎ°î4µ¿, ºÎ»ê Áß±¸ µ¿±¤µ¿3°¡, ÃæºÏ Á¦Ãµ½Ã ÀǸ²µ¿, ÃæºÏ ±«»ê±º ûõ¸é, °æ±â ºÎõ½Ã ¿ø¹Ì±¸ »ó2µ¿, ÀüºÏ Á¤À¾½Ã ½ÅÅÂÀÎÀ¾, ÀüºÏ ±º»ê½Ã ȸÇö¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ¸ð°ø°¢È­ÁõÄ¡·á ãÀ¸½Ã´Â °è»êµ¿, ÀÎõ¼­±¸, »óµ¿, ÇÐÀ͵¿, ¿ëÇöµ¿, Á־ȵ¿, ¿µÈïµµ, ½ÃÈ­, ¸¸¼öµ¿, ÀÎõ³íÇö, µ¿ÀÎõ, °Ë¾Ï, ¹è°ð½Åµµ½Ã, ´ëºÎµµ, ¿Á·Ãµ¿, ¼Û¸²µ¿, ÀÛÀüµ¿, ÀÎõ, ³²µ¿±¸, ¿ëÀ¯µµ, µ¿Ãᵿ, µ¿±¸, ºñºÀ¸é, ¼Ûµµ, µµ¸²µ¿, °¡Á¤µ¿, ¿¬¼ö±¸, Áßµ¿, ÀÎõÁÖ¾È, ¿¬¼öµ¿, ¹è°ð, ¼Û»ê¸é, ¿¬Èñµ¿, °Ë´Ü, ¼Ò·¡Æ÷±¸ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Galli E, Chini L, Nardi S, et al. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Allergol Immunopathol (Madr) 1994; 22:18. 2. Papp KA, Bissonnette R, Gooderham M, et al. Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. BMC Dermatol 2016; 16:15. 3. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 2014; 71:116. 4. Saleem MD, Oussedik E, D'Amber V, Feldman SR. Interleukin-31 Pathway and its Role in Atopic Dermatitis: A Systematic Review. J Dermatolog Treat 2017; :1. 5. Eschler DC, Klein PA. An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. J Drugs Dermatol 2010; 9:992. 6. Hanania NA, Korenblat P, Chapman KR, et al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 2016; 4:781. 7. Bleehen SS, Chu AC, Hamann I, et al. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol 1995; 133:592. 8. Michail SK, Stolfi A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2008; 101:508. 9. Panduru M, Panduru NM, Sălăvăstru CM, Tiplica GS. Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies. J Eur Acad Dermatol Venereol 2015; 29:232. 10. Novak N, Bieber T, Hoffmann M, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol 2012; 130:925.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ¸ð°ø°¢È­Áõ ½ÃÈï ±¸¿ùµ¿ Ä¡·á Ãʱ⿡ °ü¸®ÇØ¿ä""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõºñ¿° ±¸¿ùµ¿ ½ÃÈï Ä¡·á ¸¶À½¿¡ ½ïµå´Â
´ÙÀ½±Û ÀÎõÁö·ç¼ºÇǺο° ±¸¿ùµ¿ ½ÃÈï ÇÑÀÇ¿ø ÇѹæÀÌ ÁÁ¾Æ
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
892 ±èÆ÷´ÙÀ̾îÆ®ÇÑ¾à ¿ä¿ä ¿¹¹æÇϸ鼭 °Ç°­ÇÑ °ü¸® Çغ¸¼¼¿ä 2 689 2022-06-09
891 ¾È¾ç´ÙÀ̾îÆ®ÇÑ¾à °Ç°­ÇÑ Ã¼Áß °¨·® ½ÃÀÛÇغ¸¼¼¿ä 2 833 2022-06-08
890 °Ç´ë´ÙÀ̾îÆ®ÇѾàÀ¸·Î °Ç°­ÇÏ°Ô °ü¸®¸¦ ½ÃÀÛÇϼ¼¿ä 2 711 2022-06-07
889 ÇѺÀ ĸ½¶ ´ÙÀ̾îÆ®ÇÑ¾à ºñ¿ë °ÆÁ¤¾øÀÌ ½ÃÀÛ Çغ¸¼¼¿ä. 1 605 2022-05-25
888 ûÁÖ °í¸íÇÑÀÇ¿ø Áø·á¾È³» 0 779 2022-03-03
887 °æÈñ°¡Á·ÇÑÀÇ¿ø »õÇгâ¸ÂÀÌ °æ¿Á°í 3+1 À̺¥Æ® ¾È³» 0 1,061 2022-02-23
886 °íµç¸öÇÑÀÇ¿ø¿¡¼­ ´ÙÀ̾îÆ®Çϼ¼¿ä : ) 0 1,404 2022-02-23
885 [2¿ù3¿ù À̺¥Æ®] È°µ¿ÀÌ ¾ø¾îÁö¸é¼­ È®ÂðÀÚµé!!!! Çص¶ÇÏ°í ¼±¹°¹Þ¾Æ°¡.. 0 1,206 2022-02-23
884 ¿ª»ïµ¿ÇÑÀÇ¿ø ¼³¸ÂÀÌ °øÁø´Ü, °æ¿Á°í À̺¥Æ® 0 1,460 2022-01-24
883 ºÎ»ê´ÙÀ̾îÆ®ÇÑÀÇ¿ø °Ç°­ÇÑ Ã¼Áß Á¶ÀýÀ» 3 914 2022-01-24
882 ¿øÁÖ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ²ÙÁØÈ÷ Àå±â°£ µ¿¾È ÇÒ ¼ö Àִ üÁß Á¶Àý ¹æ¹ý 1 1,040 2022-01-24
881 »óºÀ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ÀÚ½ÅÀÇ °Ç°­»óÅ¿¡ ¸Â°Ô 1 748 2022-01-24
880 °Ç´ë´ÙÀ̾îÆ®ÇÑÀÇ¿ø °¨·®¿¡ ´ëÇؼ­ Àß ¾Ë°í °ü¸®¸¦ ÇÏ°í ÀÖ³ª¿ä? 2 841 2022-01-21
879 ´ëÀü´ÙÀ̾îÆ®ÇÑÀÇ¿ø °¨·®ÀÌ ½¬¿öÁö´Â ¹æ¹ýÀ̶õ? 2 1,088 2022-01-21
878 ¾È»ê´ÙÀ̾îÆ®ÇÑÀÇ¿ø °Ç°­ÇÏ°Ô °¨·®À» ÁøÇàÇØ¿ä 2 828 2022-01-21
877 ´ë±¸´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¿Ã¹Ù¸¥ ¹æ¹ýÀ¸·Î ½ÃÀÛÇØ¾ß 1 968 2022-01-21
876 ºÎõ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¸ö ¼ÓºÎÅÍ °Ç°­ÇÑ °ü¸®¸¦ ½ÃÀÛÇØ¿ä 1 912 2022-01-20
875 ½Å¸²´ÙÀ̾îÆ®ÇÑÀÇ¿ø ÀÚ¿¬°úÇÑÀÇ¿ø ¼­¿ï½Ã °ü¾Ç±¸ ½Å¸²·Î 353 ¿Ã¸®ºê¿µ.. 2 775 2022-01-20
874 â¿ø´ÙÀ̾îÆ®ÇÑÀÇ¿ø °Ç°­ÇÔÀ» ÃÖ¿ì¼±À¸·Î »ý°¢Çؼ­ 1 927 2022-01-20
873 ±èÆ÷´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¿îµ¿°ú ½Ä´ÜÁ¶ÀýÀº Æò¼Ò ó·³ ²ÙÁØÈ÷ 2 809 2022-01-20
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷